612511-81-6

• 

• Basic information

  1. Product Name: (1-Methyl-1H-pyrazol-3-yl)methylamine
  2. Synonyms: (1-Methyl-1H-pyrazol-3-yl)methylamine;3-(Aminomethyl)-1-methyl-1H-pyrazole;(1-methyl-1H-pyrazol-3-yl)methanamine;(1-methyl-3-pyrazolyl)methanamine;(1-methylpyrazol-3-yl)methanamine;(1-methylpyrazol-3-yl)methylamine
  3. CAS NO:612511-81-6
  4. Molecular Formula: C₅H₉N₃
  5. Molecular Weight: 111.14506
  6. EINECS: N/A
  7. Product Categories: N/A
  8. Mol File: 612511-81-6.mol

• Chemical Properties

  1. Melting Point: N/A
  2. Boiling Point: 219.8 °C at 760 mmHg
  3. Flash Point: 86.7 °C
  4. Appearance: /
  5. Density: 1.16 g/cm³
  6. Vapor Pressure: 0.117mmHg at 25°C
  7. Refractive Index: 1.579
  8. Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
  9. Solubility: N/A
  10. PKA: 8.23±0.29(Predicted)
  11. CAS DataBase Reference: (1-Methyl-1H-pyrazol-3-yl)methylamine(CAS DataBase Reference)
  12. NIST Chemistry Reference: (1-Methyl-1H-pyrazol-3-yl)methylamine(612511-81-6)
  13. EPA Substance Registry System: (1-Methyl-1H-pyrazol-3-yl)methylamine(612511-81-6)

• Safety Data

  1. Hazard Codes: C
  2. Statements: 34
  3. Safety Statements: 23-26-36/37/39-45
  4. WGK Germany:
  5. RTECS:
  6. HazardClass: N/A
  7. PackingGroup: N/A
  8. Hazardous Substances Data: 612511-81-6(Hazardous Substances Data)

• Suppliers
• Usage
• SDS
• Upstream product
• Downstream Products
• Article

612511-81-6 Suppliers

Recommended suppliersmore

• Product
• FOB Price
• Min.Order
• Supply Ability
• Supplier
• Contact Supplier

• (1-Methyl-1H-pyrazol-3-yl)methylamine

  Cas No: 612511-81-6

• No Data

• 10 Milligram

• Amadis Chemical Co., Ltd.
• Contact Supplier

• (1-METHYL-1H-PYRAZOL-3-YL)METHANAMINE

  Cas No: 612511-81-6

• No Data

• No Data

• No Data

• Dayang Chem (Hangzhou) Co.,Ltd.
• Contact Supplier

• (1-Methyl-1H-pyrazol-3-yl)methylamine

  Cas No: 612511-81-6

• No Data

• No Data

• 5

• Hangzhou J&H Chemical Co., Ltd.
• Contact Supplier

• C-(1-Methyl-1H-pyrazol-3-yl)-methylamine

  Cas No: 612511-81-6

• USD $ 1.9-2.9 / Gram

• 100 Gram

• 1000 Metric Ton/Month

• Chemlyte Solutions
• Contact Supplier

• (1-Methyl-1H-pyrazol-3-yl)methylamine

  Cas No: 612511-81-6

• No Data

• No Data

• No Data

• Hangzhou Fonlynn Health Technology Co., Ltd.
• Contact Supplier

• (1-Methyl-1H-pyrazol-3-yl)methylamine

  Cas No: 612511-81-6

• USD $ 10.0-10.0 / Milligram

• 1 Milligram

• 100000000 Kilogram/Month

• weifang yangxu group co.,ltd
• Contact Supplier

• (1-Methyl-1H-pyrazol-3-yl)methylamine

  Cas No: 612511-81-6

• No Data

• No Data

• No Data

• Hangzhou Huarong Pharm Co., Ltd.
• Contact Supplier

• (1-methyl-1H-pyrazol-3-yl)methanamine

  Cas No: 612511-81-6

• USD $ 10.0-10.0 / Gram

• 1 Gram

• 10 Metric Ton/Day

• LIDE PHARMACEUTICALS LIMITED
• Contact Supplier

• (1-Methyl-1H-Pyrazol-3-yl)Methylamine

  Cas No: 612511-81-6

• No Data

• No Data

• No Data

• Wuhan Circle Star Chem-medical Technology co.,Ltd.
• Contact Supplier

• 3-(AMinoMethyl)-1-Methyl-1H-pyrazole

  Cas No: 612511-81-6

• No Data

• No Data

• No Data

• Antimex Chemical Limied
• Contact Supplier

612511-81-6 Usage

Uses

Used in Organic Synthesis:
(1-Methyl-1H-pyrazol-3-yl)methylamine is utilized as a reagent in organic synthesis, particularly for the formation of heterocyclic compounds. Its ability to participate in various chemical reactions makes it a valuable component in the creation of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (1-Methyl-1H-pyrazol-3-yl)methylamine is studied for its potential pharmacological properties. It has demonstrated activity as a ligand for metal complexes, which can be significant in the development of new drugs with specific therapeutic targets.
Used in Drug Development:
(1-Methyl-1H-pyrazol-3-yl)methylamine is also considered a promising building block in the development of bioactive compounds. Its incorporation into drug candidates can lead to the discovery of new therapeutic agents with improved efficacy and selectivity for various medical conditions.
While the specific applications in different industries are not detailed in the provided materials, the general uses outlined above reflect the compound's versatility and potential across various sectors, including chemical manufacturing and pharmaceutical development.

Check Digit Verification of cas no

The CAS Registry Mumber 612511-81-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,1,2,5,1 and 1 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 612511-81:
(8*6)+(7*1)+(6*2)+(5*5)+(4*1)+(3*1)+(2*8)+(1*1)=116
116 % 10 = 6
So 612511-81-6 is a valid CAS Registry Number.

InChI:InChI=1/C5H9N3/c1-8-3-2-5(4-6)7-8/h2-3H,4,6H2,1H3

612511-81-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name	(1-methylpyrazol-3-yl)methanamine

1.2 Other means of identification

Product number	-
Other names	1-(1-methyl-1H-pyrazol-3-yl)methanamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses	For industry use only.
Uses advised against	no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number	-
Service hours	Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:612511-81-6 SDS

612511-81-6Upstream product

• 89179-62-4 1-methyl-1H-pyrazole-3-carboxamide 
• 79080-39-0 1-Methylpyrazole-3-carboxylic acid nitrile 
• 17827-61-1 methyl ester of 1-methylpyrazole-3-carboxylic acid 
• 25016-20-0 1-methylpyrazole-3-carboxylic acid 

612511-81-6Downstream Products

• 1219623-45-6 N-[(1-methyl-1H-pyrazol-3-yl)methyl]-2-(2-oxo-3,3-diphenylpyrrolidin-1-yl)acetamide 
• 1196886-83-5 2-amino-4-chloro-7-((1-methyl-1H-pyrazol-3-yl)methyl)-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one 
• 1400872-78-7 trans-N-[3-(2-{[(1-methyl-1H-pyrazol-3-yl)methyl]amino}pyrimidin-5-yl)imidazo[1,2-b]pyridazin-6-yl]cyclohexane-1,4-diamine 
• 1401618-77-6 1-(1-(4-chlorobenzyl)-1H-indole-2-carbonyl)-N-((1-methyl-1H-pyrazol-3-yl)methyl)piperidine-4-carboxamide 

612511-81-6Relevant articles and documents

5-(1 H-BENZO[D]IMIDAZO-2-YL)-PYRIDIN-2-AMINE AND 5-(3H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-PYRIDIN-2-AMINE DERIVATIVES AS C-MYC AND P300/CBP HISTONE ACETYLTRANSFERASE INHIBITORS FOR TREATING CANCER

-

Page/Page column 334, (2019/04/10)

The invention is directed to substituted 5-(1H-benzo[d]imidazo-2-yl)- pyridin-2-amine and 5-(3H-imidazo[4,5-b]pyridin-6-yl)-pyridin-2-amine derivatives. Specifically, the invention is directed to compounds according to Formula (lb) wherein R', R2', R3', R4', Rs', R6', R7', and X1' are as defined herein; or a salt thereof including a pharmaceutically acceptable salt thereof. The compounds of the invention decrease MYC protein (c-MYC) in cells and/or inhibit p300/CBP histone acetyltransferase and can be useful in the treatment of cardiac hypertrophy, diabetes, obesity and nonalcoholic fatty liver disease, HIV, polycystic kidney disease, inflammatory diseases, ankylosing spondylitis, psoriasis, psoriatic arthritis, rheumatoid arthritis, Crohn's disease, multiple sclerosis, cancer and pre-cancerous syndromes, and diseases associated with dysregulation of Myc or inhibition of p300/CBP histone acetyltransferase. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention still further discloses methods of reducing MYC protein (c-MYC) in cells and inhibiting p300/CBP histone acetyltransferase activity, and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

SUBSTITUTED PYRIDIZINONE DERIVATIVES AS PDE10 INHIBITORS

-

Page/Page column 65; 66, (2014/09/29)

The present invention is directed to substituted pyridizinone compounds of formula (I) which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

SUBSTITUTED PYRIDIZINONE DERIVATIVES AS PDE10 INHIBITORS

-

Page/Page column 66, (2014/10/04)

The present invention is directed to substituted pyridizinone compounds of formula I which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

NOVEL COMPOUNDS

-

Page/Page column 50-51, (2008/06/13)

Compounds of formula (I) wherein: R1 represents substituted or unsubstituted heteroaryl; Y represents -(CRnaRnb)n-; Rna and Rnb are each independently hydrogen or C1-6alkyl; n is an integer from 0 to 5;R2 represents unsubstituted or substituted aryl or un

Post a RFQ

Cas No.:

Product Name:

Quantity:

Please select Metric Ton KG G Pound L ML

Email:

Company name:

Valid Period:

Detailed Requirements:

• Sample
• MOQ
• GMP
• FDA
• Price
• Urgent purchase

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

Remove

Submit

1

What can I do for you?
Get Best Price

Get Best Price for 612511-81-6 (1-Methyl-1H-pyrazol-3-yl)methylamine

Send

Send

Metric Ton KG G Pound L ML

Send

Send